Seres Therapeutics Inc (MCRB) Volatility Spurs A Quest For Clarity
Currently, there are 135.04M common shares owned by the public and among those 119.44M shares have been available to trade. The company’s stock has a 5-day price change of -10.33% and -48.28% over the past three months. MCRB shares are trading -54.56% year to date (YTD), with the 12-month market performance down to -89.15% lower. […]
Do Seres Therapeutics Inc (NASDAQ: MCRB) Fit In A Value Investing Philosophy?
Currently, there are 135.04M common shares owned by the public and among those 114.13M shares have been available to trade. The company’s stock has a 5-day price change of -7.00% and -54.53% over the past three months. MCRB shares are trading -49.33% year to date (YTD), with the 12-month market performance down to -87.71% lower. […]
Better Times Ahead For Seres Therapeutics Inc (NASDAQ: MCRB)?
Seres Therapeutics Inc (MCRB) concluded trading on Wednesday at a closing price of $0.73, with 6.07 million shares of worth about $4.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.25% during that period and on April 3, 2024 the price saw a […]
Seres Therapeutics Inc (NASDAQ: MCRB): Analyst View Points To Future Growth
Seres Therapeutics Inc (MCRB) concluded trading on Wednesday at a closing price of $0.78, with 3.29 million shares of worth about $2.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.52% during that period and on March 27, 2024 the price saw a […]
Uncovering Institutional Buying In Seres Therapeutics Inc (NASDAQ: MCRB)
Currently, there are 135.04M common shares owned by the public and among those 114.13M shares have been available to trade. However, the script later moved the day high at 0.8539, up 6.34%. The company’s stock has a 5-day price change of 4.32% and -18.76% over the past three months. MCRB shares are trading -42.40% year […]
Now Is A Suitable Moment For A Long-Term Purchase Of Seres Therapeutics Inc (NASDAQ: MCRB)
Currently, there are 135.04M common shares owned by the public and among those 114.13M shares have been available to trade. The company’s stock has a 5-day price change of -27.08% and -29.08% over the past three months. MCRB shares are trading -44.79% year to date (YTD), with the 12-month market performance down to -85.30% lower. […]
Handle With Care: Seres Therapeutics Inc (NASDAQ: MCRB)
Currently, there are 125.22M common shares owned by the public and among those 97.76M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Handle With Care: Seres Therapeutics Inc (NASDAQ: MCRB)
Currently, there are 125.22M common shares owned by the public and among those 97.76M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Seres Therapeutics Inc (MCRB): Insights At A Glance
Seres Therapeutics Inc (MCRB) concluded trading on Thursady at a closing price of $1.10, with 4.32 million shares of worth about $4.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -69.19% during that period and on Thursady the price saw a gain of […]
Seres Therapeutics Inc (NASDAQ: MCRB): Reassessing Prospects
Seres Therapeutics Inc (MCRB) concluded trading on Wednesday at a closing price of $1.02, with 3.69 million shares of worth about $3.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.22% during that period and on Wednesday February 7 the price saw a […]
